Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Stock Score, Valuation & Financial Research
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 23/100.
Quick answer for CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares currently has a Wall Street Score of 23/100. The stored market price is $1.6. Its financial score is 3/100. Its valuation score is 0/100. The latest WSS change is +1.5 points. These figures are a research snapshot, not a buy or sell recommendation.
What Cuprina Holdings (Cayman) Limited Class A Ordinary Shares does
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
CUPR financial snapshot
- Wall Street Score:
- 23/100
- Current price:
- $1.6
- Market capitalization:
- $4.3M
- Revenue:
- $39K
- Net income:
- $-3.7M
- Free cash flow:
- $-7.2M
- Cash:
- $2.4M
- Total debt:
- $378K
- EPS:
- -1.44
- Financial score:
- 3/100
- Valuation score:
- 0/100
- Revenue score:
- 3/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $-7.2M, showing cash burn in the current stored period.
- The balance sheet shows $2.4M of cash versus $378K of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +1.5 points: CUPR increased 1.5 points because Asset improved by 15.7 points, Buffett improved by 2.3 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 3/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-17.
How to research CUPR
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.